Economía y Política

UE endurece control de exportación de vacunas anticovid producidas dentro de su territorio

A partir de ahora se deberán considerar “dos elementos adicionales” para autorizar exportaciones: reciprocidad con el país de origen y proporcionalidad en los pedidos

A medical worker prepares a vial of the AstraZeneca vaccine against Covid-19 on March 19, 2021 at the San Giovanni Bosco Hospital in Turin. - Italy on March 19, 2021 again began administering AstraZeneca vaccines, five days after suspending the programme over safety fears despite the worsening coronavirus situation. The European Medicines Agency (EMA) on March 18 declared the jab "safe and effective", and Italy's AIFA regulator subsequently lifted its nationwide ban. (Photo by Marco Bertorello / AFP) (MARCO BERTORELLO/AFP)
‌
‌

‌

‌
‌

‌

‌